Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Berchuck

Showing results (301-310 of 681) with videos related to

Pageof 69
Sort By:
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 4, 2006
High expression of insulin-like growth factor binding protein-2 messenger RNA in epithelial ovarian cancers produces elevated preoperative serum levelsJ M Lancaster, R A Sayer, C Blanchette, et al.
Gynecologic Oncology|January 11, 1992
Ploidy analysis of epithelial ovarian cancers using image cytometryA Berchuck, M P Boente, B J Kerns, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 7, 2006
Prediction of lymph node metastasis in patients with endometrioid endometrial cancer using expression microarrayMichael A Bidus, John I Risinger, Gadisetti V R Chandramouli, et al.
Biorxiv : the Preprint Server for Biology|September 24, 2024
Regulation of Age-Related Lipid Metabolism in Ovarian CancerJihua Feng, Clay Douglas Rouse, Isabella Coogan, et al.
Cancer Research|April 15, 1989
Immunohistochemical expression of CA 125 in endometrial adenocarcinoma: correlation of antigen expression with metastatic potentialA Berchuck, A P Soisson, D L Clarke-Pearson, et al.
Molecular Cancer Research : MCR|April 11, 2006
Frequent IGF2/H19 domain epigenetic alterations and elevated IGF2 expression in epithelial ovarian cancerSusan K Murphy, Zhiqing Huang, Yaqing Wen, et al.
Gynecologic Oncology|March 30, 1999
Combination of multiple serum markers using an artificial neural network to improve specificity in discriminating malignant from benign pelvic massesZ Zhang, S D Barnhill, H Zhang, et al.
Gynecologic Oncology|September 1, 1990
High-dose alkylating agent chemotherapy with autologous bone marrow support in patients with stage III/IV epithelial ovarian cancerE J Shpall, D Clarke-Pearson, J T Soper, et al.
Experimental Cell Research|August 1, 1993
Constitutive production of macrophage colony-stimulating factor and interleukin-6 by human ovarian surface epithelial cellsY J Lidor, F J Xu, O Martínez-Maza, et al.
Gynecologic Oncology|October 1, 1995
Combinations of multiple serum markers are superior to individual assays for discriminating malignant from benign pelvic massesR P Woolas, M R Conaway, F Xu, et al.
Pageof 69

Showing results (301-310 of 681) with videos related to

Sort By:
Pageof 69
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 4, 2006
High expression of insulin-like growth factor binding protein-2 messenger RNA in epithelial ovarian cancers produces elevated preoperative serum levelsJ M Lancaster, R A Sayer, C Blanchette, et al.
Gynecologic Oncology|January 11, 1992
Ploidy analysis of epithelial ovarian cancers using image cytometryA Berchuck, M P Boente, B J Kerns, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 7, 2006
Prediction of lymph node metastasis in patients with endometrioid endometrial cancer using expression microarrayMichael A Bidus, John I Risinger, Gadisetti V R Chandramouli, et al.
Biorxiv : the Preprint Server for Biology|September 24, 2024
Regulation of Age-Related Lipid Metabolism in Ovarian CancerJihua Feng, Clay Douglas Rouse, Isabella Coogan, et al.
Cancer Research|April 15, 1989
Immunohistochemical expression of CA 125 in endometrial adenocarcinoma: correlation of antigen expression with metastatic potentialA Berchuck, A P Soisson, D L Clarke-Pearson, et al.
Molecular Cancer Research : MCR|April 11, 2006
Frequent IGF2/H19 domain epigenetic alterations and elevated IGF2 expression in epithelial ovarian cancerSusan K Murphy, Zhiqing Huang, Yaqing Wen, et al.
Gynecologic Oncology|March 30, 1999
Combination of multiple serum markers using an artificial neural network to improve specificity in discriminating malignant from benign pelvic massesZ Zhang, S D Barnhill, H Zhang, et al.
Gynecologic Oncology|September 1, 1990
High-dose alkylating agent chemotherapy with autologous bone marrow support in patients with stage III/IV epithelial ovarian cancerE J Shpall, D Clarke-Pearson, J T Soper, et al.
Experimental Cell Research|August 1, 1993
Constitutive production of macrophage colony-stimulating factor and interleukin-6 by human ovarian surface epithelial cellsY J Lidor, F J Xu, O Martínez-Maza, et al.
Gynecologic Oncology|October 1, 1995
Combinations of multiple serum markers are superior to individual assays for discriminating malignant from benign pelvic massesR P Woolas, M R Conaway, F Xu, et al.
Pageof 69